BlackRock Institutional Trust’s Fortress Biotech FBIO Stock Holding History

BlackRock Institutional Trust’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$983K	Buy	24,262 +3,267	+16%	+$122K	﹤0.01%	3297
2016 Q3	$935K	Hold	20,995	–	–	﹤0.01%	3323
2016 Q2	$847K	Buy	20,995 +11,862	+130%	+$552K	﹤0.01%	3367
2016 Q1	$425K	Hold	9,133	–	–	﹤0.01%	3492
2015 Q4	$382K	Hold	9,133	–	–	﹤0.01%	3552
2015 Q3	$356K	Sell	9,133 -219	-2%	-$10.2K	﹤0.01%	3561
2015 Q2	$471K	Buy	9,352 +4,232	+83%	+$217K	﹤0.01%	3514
2015 Q1	$296K	Buy	5,120 +682	+15%	+$28.4K	﹤0.01%	3594
2014 Q4	$162K	Buy	4,438 +23	+0.5%	+$677	﹤0.01%	3668
2014 Q3	$139K	Buy	4,415 +1,607	+57%	+$42.7K	﹤0.01%	3649
2014 Q2	$72K	Sell	2,808 -22,792	-89%	-$601K	﹤0.01%	3783
2014 Q1	$760K	Buy	25,600 +4,613	+22%	+$180K	﹤0.01%	3494
2013 Q4	$828K	Sell	20,987 -1,503	-7%	-$58K	﹤0.01%	3450
2013 Q3	$2.37M	Buy	22,490 +6,627	+42%	+$812K	﹤0.01%	3044
2013 Q2	$2.05M	Buy	+15,863	New	+$2.34M	﹤0.01%	3055

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

BlackRock Institutional Trust's FBIO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Fortress Biotech (FBIO) stake by 16% in Q4 2016, buying an estimated $122K and bringing the position to 24,262 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

BlackRock Institutional Trust first reported a position in FBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.37M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.

BlackRock Institutional Trust held 24,262 shares of Fortress Biotech worth $983K as of Q4 2016.
BlackRock Institutional Trust bought 3,267 Fortress Biotech shares in Q4 2016, an estimated $122K.
Fortress Biotech made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3297 holding.
BlackRock Institutional Trust first reported a position in Fortress Biotech in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Fortress Biotech position peaked at $2.37M in Q3 2013.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.